{"id":"NCT03159611","sponsor":"Materia Medica Holding","briefTitle":"Efficacy and Safety Clinical Trial of Tenoten for Children Liquid Dosage Form Therapy in Infants With Sequelae of Perinatal Brain Injury","officialTitle":"Multicenter Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficacy and Safety of Tenoten for Children Liquid Dosage Form Therapy in Infants With Sequelae of Perinatal Brain Injury","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-02-19","primaryCompletion":"2018-02-09","completion":"2018-02-09","firstPosted":"2017-05-19","resultsPosted":"2019-04-08","lastUpdate":"2019-08-08"},"enrollment":182,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Sequelae of Perinatal Brain Injury"],"interventions":[{"type":"DRUG","name":"Tenoten for children","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Tenoten for children","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Purpose of the study:\n\n* To assess the clinical efficacy of Tenoten for children liquid dosage form therapy (10 oral drops per day for 12 weeks) in Infants with Sequelae of Perinatal Brain Injury (mild-to-moderate cerebral hypoxia-ischaemia and/or mild-to-moderate intracranial haemorrhage).\n* To assess the safety of Tenoten for children liquid dosage form therapy (10 oral drops per day for 12 weeks) in Infants with Sequelae of Perinatal Brain Injury (mild-to-moderate cerebral hypoxia-ischaemia and/or mild-to-moderate intracranial haemorrhage).","primaryOutcome":{"measure":"Percentage of Patients With a 4 and More Point Increase of the Total Score According to Jurba-Mastyukova Psychomotor Development Scale by the End of the Treatment","timeFrame":"in 12 weeks of the treatment","effectByArm":[{"arm":"Tenoten for Children","deltaMin":86.1,"sd":null},{"arm":"Placebo","deltaMin":62.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.002"}]},"eligibility":{"minAge":"29 Days","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":10,"countries":["Russia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":87},"commonTop":["Respiratory tract infection","Teething","Nasopharyngitis","Pyrexia","Rickets"]}}